Insights On Trial Design
-
Digital Front Door Improves Patient And Clinician Satisfaction
8/8/2023
Glean insight into how sponsors are amplifying patient access and involvement, while simultaneously mitigating clinician exhaustion.
-
Clinical Trials, Meet Adaptive Design
2/14/2024
Learn about adaptive design (AD) trials that reduce clinical trial time and cost while enhancing patient safety by minimizing exposure to unsafe or ineffective treatments.
-
Decentralized Study Guidance Part II
7/14/2023
Part two of this series reveals four more essential decentralized trial guidance takeaways and how teams can achieve compliant and streamlined DCT implementation.
-
Cervical Cancer - Global Clinical Trial Landscape (2024)
10/15/2024
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
-
Mobile Visits Are Key To Decentralizing Rare Disease Research
4/8/2024
Discover how mobile visits revolutionize rare disease research, bridging gaps in clinical trial accessibility and enhancing patient engagement for conditions like Rett Syndrome.
-
How Will The Ophthalmologist Shortage Impact Your Next Study?
1/29/2025
With a shortage of ophthalmologists affecting patients in both ophthalmic and non-ophthalmic clinical trials, the industry is looking for new solutions to ensure trial success and efficiency.
-
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data
2/25/2025
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
DCTs: The Site Perspective
5/8/2024
Putting patients and sites on the same platform coordinates and simplifies eCOA patient data collection and provides a 360 degree view of the patient. See how through Dr. Aaliyah's story.
-
The Path Forward, Altasciences' Approach To Project Management
3/19/2024
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
-
Key Takeaways From The Recent FDA DCT Draft Guidance
8/7/2023
Get an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.